Kontravesta - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 91,020 | 97,946 | 97,910 | 105,450 | 179,175 | 184,628 | 189,786 | 169,943 |
| Profit before tax | 379 | -3,130 | 5,290 | -10,792 | -7,170 | -7,671 | -3,524 | -11,331 |
| Net profit | 379 | -3,130 | 5,284 | -10,792 | -7,170 | -7,671 | -3,524 | -11,331 |
| Equity | -256,495 | -259,625 | -254,341 | -265,133 | -272,303 | -279,974 | -283,498 | -294,829 |
| Liabilities | 280,451 | 282,536 | 277,127 | 1,524,935 | 1,533,479 | 1,532,200 | 1,532,871 | 1,541,392 |
| Non-current assets | 6 | 6 | 6 | 1,220,006 | 1,220,006 | 1,220,006 | 1,220,377 | 1,220,242 |
| Current assets | 23,766 | 22,698 | 22,753 | 39,747 | 41,113 | 32,187 | 28,895 | 26,189 |
| Total assets | 23,772 | 22,704 | 22,759 | 1,259,753 | 1,261,119 | 1,252,193 | 1,249,272 | 1,246,431 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 22,517 | 21,728 | 18,442 |
| Social insurance contributions | - | - | - | - | - | 23,349 | 22,901 | 19,001 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.6% | +7.6% | 0.0% | +7.7% | +69.9% | +3.0% | +2.8% | -10.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.6% | -13.8% | 23.2% | -0.9% | -0.6% | -0.6% | -0.3% | -0.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.4% | -3.2% | 5.4% | -10.2% | -4.0% | -4.2% | -1.9% | -6.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.4% | -3.2% | 5.4% | -10.2% | -4.0% | -4.2% | -1.9% | -6.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 3,806 | 4,198 | 4,662 | 5,502 | 8,532 | 8,688 | 9,733 | 8,752 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Kontravesta - Social security debts
The company had no debts to Sodra
Kontravesta - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Kontravesta is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-09-02 | 0.42 |
| 2025-02-20 | 2026-01-30 | 0.42 |
| 2024-02-17 | 2025-01-30 | 0.42 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Kontravesta, UAB (code 302473510) is a Private Limited Liability Company operating in medical specialists activities. In 2025, revenue amounted to €169.9K, down 10.5% year on year and 8.0% below the 2023 level. The company remained loss-making, posting a net loss of €11.3K in 2025 versus a loss of €3.5K in 2024 and €7.7K in 2023. The net profit margin widened to -6.7% in 2025 after -1.9% in 2024 and -4.2% in 2023, indicating weaker profitability in the latest year. The balance sheet remained broadly stable, with total assets of €1.25M, liabilities of €1.54M, and negative equity of €294.8K at the end of 2025. Most assets were long-term, at €1.22M, while short-term assets stood at €26.2K. Asset turnover was 0.14x, showing limited revenue generation relative to asset base. Revenue per employee was €8.9K, and profit per employee was -€596. Ratios based on equity are constrained by the negative equity position.